EDIT FY 2025 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

$0

Net Income

-$160M

EPS (Diluted)

$-1.80

Cash Flow

Operating Cash Flow

-$165M

Free Cash Flow

-$166M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$187M

Total Liabilities

$159M

Stockholders' Equity

$27M

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$32M	-100.0%
Gross Profit	$0	$32M	-100.0%
Operating Income	$0	-$251M	+100.0%
Net Income	-$160M	-$237M	+32.5%